Komori
Stella Chemifa (4109) · TargetAdvanced

Growth Investment Amount under the 3rd Medium-Term Management Plan

First written in FY2023. 2 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2026.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024 – FY20262023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Capital Expenditure and Research and Development Investment Allocation in the Medium-Term PlanA theme 7 companies write about · 0 as a headwind · 7 as a tailwind

4 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Capital investment for the current consolidated fiscal year totaled ¥4,235 million for the Group, including intangible fixed assets. In the High-Purity Chemicals business, the Company made ¥4,006 million in capital investment, primarily to develop facilities for manufacturing ultra-high-purity hydrofluoric acid.」

    As part of executing growth investments under the Fourth Medium-Term Management Plan, the Company invested a total of ¥4,235 million during the fiscal year, including ¥4,006 million in facilities for manufacturing ultra-high-purity hydrofluoric acid for the High-Purity Chemicals business.
  2. FY2024AdvancedAnnual report

    「Under the ongoing Third Medium-Term Management Plan, the Company plans to allocate approximately ¥13 billion to capital and IT investment and approximately ¥5 billion to research and development investment as growth investments over the 3 years of the plan.」

    While continuing the growth investment plan under the Third Medium-Term Management Plan, the Company made ¥5,708 million in capital investment and other investments during the fiscal year.
  3. FY2023First statedAnnual report

    「Over the 3 years of this medium-term management plan, the Company plans to allocate approximately ¥13 billion to capital and IT investment and approximately ¥5 billion to research and development investment as growth investments.」

    For the 3 years of the Third Medium-Term Management Plan, the Company has disclosed for the first time specific amounts for its growth investment plan: approximately ¥13 billion in capital and IT investment and approximately ¥5 billion in research and development investment.
Moved together

"Dependence on Specific Sources, Including China, for Raw Materials and Exposure to Sharp Price Increases" moved the same way as this thread, in the same document, in 2 of its 3 moves.

2222★1234
  1. ★This thread
  2. 1Dependence on Specific Sources, Including China, for Raw Materials and Exposure to Sharp Price Increases2×
  3. 2Management of Material Issues and KPIs by the Sustainability Committee2×
  4. 3Shareholder Returns Through Dividends from Retained Earnings2×
  5. 4Human Capital KPIs and Targets for the Fiscal Year Ending March 20252×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Stella Chemifa yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Growth Investment Amount under the 3rd Medium-Term Management Plan | STELLA CHEMIFA CORPORATION (4109) | Komori